Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The Biden Administration's emphasis on "antitrust on steroids" and more regulation has harmed the American economy. The next ...
WWLP Springfield on MSN1d
Federal Trade Commission finds social and video streaming services pose serious privacy risksA Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
California courts were home to the most federal trade secrets litigation over the past three years, according to a report ...
Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback